Abstract:There has also been a growing interest in the application of carbohydrates as pharmaceutical drugs in the field of invasive bacterial diseases, inflammatory diseases, and viral infections. Chemical oligosaccharide synthetic procedures often require tedious protection and deprotection steps. Enzymatic synthesis offers tremendous benefits because of its high regio- and stereoselectivities, stability, organic solvent compatibility, and low cost. Glycosyltransferase-catalyzed synthesis of carbohydrates has been recognized as one of the most practical approaches for its high efficiency and specificity under very mild conditions. The two main obstacles in the enzymatic synthesis of carbohydrates are the inadequate availability of glycosyltransferases and the high cost of sugar nucleotides, which serve as intermediates. Significant progress in the study of the enzymatic biosynthesis of complex carbohydrates has been made with developments in protein purification, molecular genetics, and new methods of enzymological analysis. Bioinformatics provide a large amount of putative candidates for carbohydrate active enzymes. The combined enzymatic and genetic approach has overcome formidable obstacles ubiquitous to the study of glycans, and has begun to yield new information that definitively addresses basic enzymological issues relevant to these complex carbohydrates. In fact, complex carbohydrates representing the glycan chain of gangliosides such as GT2, GM1, and GD1a were synthesized using glycosyltransferases. Although traditional cell-free enzymatic synthesis of oligosaccharides will continue to be used in laboratory scale synthesis, the future direction for large-scale preparation of complex oligosaccharides and polysaccharides will be whole-cell systems. Further development of these enzymatic methods will allow synthetic biochemists to create important molecular tools for biochemical, biophysical, and medical applications.

Development of Kilogram-Scale Convergent Liquid-Phase Synthesis of Oligonucleotides.

Enzymatic Synthesis of Oligosaccharides and Conversion to Glycolipids

The Commercial-Scale Production of Oligonucleotides.

Scalable One-Pot - Liquid-Phase Oligonucleotide Synthesis for Model Network Hydrogels.

Recent Advances in Scale-Up of Modified Oligodeoxynucleotides.

An enzyme cascade enables production of therapeutic oligonucleotides in a single operation

Long Oligos: Direct Chemical Synthesis of Genes with up to 1,728 Nucleotides

Convergent Biocatalytic Mediated Synthesis of siRNA.

Modern approaches to therapeutic oligonucleotide manufacturing

A Short, Novel, and Cheaper Procedure for Oligonucleotide Synthesis Using Automated Solid Phase Synthesizer

Integrated multidimensional chromatography on preparative scale for oligonucleotides purification

For Catching-by-Polymerization Oligo Purification: Scalable Synthesis of the Precursors to the Polymerizable Tagging Phosphoramidites

A Simple and Efficient Microfluidic System for Reverse Chemical Synthesis (5′-3′) of a Short-Chain Oligonucleotide Without Inert Atmosphere

Characterization of Oligodeoxyribonucleotide Synthesis on Glass Plates

Optimized Kilogram-Scale Synthesis and Impurity Identification of SHEN26 (ATV014) for Treating COVID-19

Bead-Droplet Reactor for High-Fidelity Solid-Phase Enzymatic DNA Synthesis

Toward a large-batch manufacturing process for silicon-stabilized lipid nanoparticles: A highly customizable RNA delivery platform

Tuning the Solubility of Soluble Support Constructs in Liquid Phase Oligonucleotide Synthesis

An oligonucleotide synthesizer based on a microreactor chip and an inkjet printer

Fully automated fast-flow synthesis of antisense phosphorodiamidate morpholino oligomers

Template-independent enzymatic synthesis of RNA oligonucleotides